CorMedix (CRMD) Tops Q2 EPS by 2c

CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Is the S&P 500 in an "earnings bubble"? Goldman weighs in
• Jana Partners urges Cooper Companies to replace CEO and explore asset sales
• BofA Securities Reiterates Underperform Rating on HubSpot Inc (HUBS)